STOCK TITAN
  1. Home
  2. Sec-filings
  3. VICR
  4. [144] VICOR CORP SEC Filing

VICR (NASDAQ) shows repeated 10b5-1 sales by Patrizio Vinciarelli, multiple dates

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

VICR: Multiple proposed sales of common shares reported on Form 144. The filing lists numerous 10b5-1 sales attributed to Patrizio Vinciarelli and several institutionally named holders, showing individual sale transactions (for example, 20,000 shares on multiple June 2026 dates and 50,000 shares on 04/15/2026). The entries identify trade dates and share counts for each planned sale.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists repeated planned disposals under 10b5-1 by an individual and institutional holders.

The filing records a sequence of proposed sales identified as 10b5-1 sales for Patrizio Vinciarelli with explicit trade dates and share counts, including multiple 20,000-share entries in June 2026 and larger blocks in April 2026.

These entries are procedural notices of intended sales; cash‑flow recipients and net proceeds treatment are not stated in the excerpt. Subsequent Form 4 or trade confirmations would show completed transactions and resulting holdings.

Example June 2026 sale entries 20,000 shares multiple dates in June 2026 (e.g., 06/22/2026, 06/18/2026)
Notable April 2026 block 50,000 shares 04/15/2026 reported 10b5-1 sale by Patrizio Vinciarelli
April 16, 2026 entry 40,000 shares 04/16/2026 reported 10b5-1 sale by Patrizio Vinciarelli
Institutional examples 3,500 shares Brigham and Women's Hospital and Lahey Hospital & Medical Center on 05/14/2026
March 25, 2026 block 50,000 shares 03/25/2026 reported 10b5-1 sale by Patrizio Vinciarelli
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 11/10/1981 | Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What does VICR's Form 144 show about insider selling?

It lists planned disposals of common shares by named holders. The excerpt shows multiple 10b5-1 sales by Patrizio Vinciarelli, including several 20,000-share entries in June 2026 and larger blocks in April 2026, with each row giving date and share count.

Are the sales in the Form 144 already completed for VICR?

No completion is confirmed in this excerpt. The filing records proposed or reported sales with trade dates and share counts; whether each sale settled or the cash recipients are not disclosed here. Trade confirmations or Form 4s would confirm completion and proceeds.

Who is repeatedly listed as selling VICR shares in the filing?

The filing repeatedly lists Patrizio Vinciarelli as the reporting holder for multiple 10b5-1 sale entries, including many 20,000-share transactions in June 2026 and several larger blocks in April and March 2026, with dates and dollar amounts shown per row.

Does the Form 144 specify the method or plan for the VICR sales?

Yes; many entries are labeled as 10b5-1 sales, indicating planned sales under a trading plan. The excerpt identifies specific trade dates and share counts but does not include plan adoption dates or additional plan terms in the provided text.

Are institutional entities listed as sellers for VICR in this filing?

Yes. The excerpt includes named institutional recipients or holders such as Brigham and Women's Hospital and Lahey Hospital & Medical Center with listed sale rows (each 3,500 shares on 05/14/2026), shown alongside individual entries for Mr. Vinciarelli.